Associations of Serological Biomarkers of sICAM-1, IL-1<i>β</i>, MIF, and su-PAR with 3-Month Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

<div>Flowchart of the patients’ enrollment. Thirty-seven patients were newly diagnosed with IPF; eighty-five patients had previously been diagnosed with IPF, and 35 of them develop AE-IPF.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: Associations of Serological Biomarkers of sICAM-1, IL-1<i>β</i>, MIF, and su-PAR with 3-Month Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis 

Figure 1 | Associations of Serological Biomarkers of sICAM-1, IL-1β, MIF, and su-PAR with 3-Month Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis 